Trial NCT06006286

View at ClinicalTrials.gov 
Org. Study IDs: 2023-0208
Secondary IDs: NCI-2023-06581

Last trial update was posted on 2023-11-15

MeSH Interventions

Atezolizumab Bevacizumab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Metastatic Hepatocellular Carcinoma

Stopping Reasons

0 participants registered

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID